MedPath

Validation hepatotoxicity-predictor-algorithm for patients with thiopurine drugs; A prospective observational study

Conditions
thiopurine drugshepatotoxicity
Registration Number
NL-OMON26269
Lead Sponsor
n.a.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
200
Inclusion Criteria

• age > 18 years

• patient agrees to take part in the study (signed informed consent)

Exclusion Criteria

• Known hypersensitivity to active substance or any of the excipients

• Leukocytes <3 x 10^9 /l on baseline

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
hepatotoxicity
Secondary Outcome Measures
NameTimeMethod
leukopenia<br /><br>GI-complaints
© Copyright 2025. All Rights Reserved by MedPath